Suven gets three process patents for neuro-degenerative drug

Firm was granted one patent each by Europe, Japan, New Zealand

Hyderabad-based bio pharmaceutical company Suven Life Sciences has received process patents for its new chemical entities(NCE) from Europe, Japan and New Zealand. The process patents are for a pipeline of compounds being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neuro-degenerative disorders such as Alzheimer's and Attention Deficiency Syndrome(ADHD), among others, said the company.

"We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally," said Venkat Jasti,